MedTrace Logo

Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study.

NCT00321256 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2012-03-02

No results posted yet for this study

Summary

This research project is supported by a multicentric network of collaborators whose goal is to assess the efficacy of transplanting allogenic pancreas islets to restore insulin secretion in patients with brittle type 1, insulin-dependent diabetes mellitus and to improve their metabolic control.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

PROCEDURE

human pancreatic islet transplantation

Sponsors & Collaborators

  • Alfediam

    collaborator OTHER

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Pierre Y Benhamou, MD, PhD · Universty Hospital, Grenoble, France

  • Philippe Morel, MD, PhD · University Hospital, Geneva, Switzerland

  • Charles Thivolet, MD, PhD · Hospices Civils de Lyon

  • Alfred Penfornis, MD, PhD · University Hospital, Besancon, France

  • Laurence Kessler, MD, PhD · University Hospital, Strasbourg, France

  • Eric Renard, MD, PhD · University Hospital, Montpellier France

  • Lionel Badet, MD, PhD · Hospices Civils de Lyon

  • Cyrille Colin, MD, PhD · Hospices Civils de Lyon

  • Thierry Berney, MD, PhD · University Hospital, Geneva, Switzerland

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Completion
2007-07-31

Countries

  • France
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00321256 on ClinicalTrials.gov